Cargando…
Correlation of preclinical and clinical biomarkers with efficacy and toxicity of cancer immunotherapy
Immune checkpoint inhibitors (ICIs) have revealed significant clinical values in different solid tumors and hematological malignancy, changing the landscape for the treatment of multiple types of cancer. However, only a subpopulation of patients has obvious tumor response and long-term survival afte...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126660/ https://www.ncbi.nlm.nih.gov/pubmed/37113734 http://dx.doi.org/10.1177/17588359231163807 |